Form 4: Aspira Women's Health Director Converts Restricted Stock Units to Common Shares
Insider Ownership Change
Aspira Women's Health Inc. Director Ellen Beausang has converted 4,843 restricted stock units into common stock following their vesting on June 4, 2025.
Summary
- Ellen Beausang, a Director of Aspira Women's Health Inc. (AWHL), acquired 4,843 shares of common stock.
- This acquisition resulted from the vesting and conversion of restricted stock units (RSUs) on June 4, 2025.
- The RSUs were originally granted on March 11, 2025, totaling 6,458 units, with 4,843 units vesting on the reported date.
- The conversion price for these shares was $0.
- Following this transaction, Ellen Beausang directly beneficially owns 6,458 shares of Aspira Women's Health Inc. common stock.
- The RSUs converted were previously reported in a Form 4 filed on April 1, 2025.
Sentiment
Score: 6
Explanation: The filing reports a routine, expected compensation event (RSU vesting) for a director, which is generally neutral but can be seen as slightly positive as it aligns insider interests with shareholders. It contains no negative news or unexpected events.
Positives
- The vesting of restricted stock units represents a successful compensation event for the director, aligning their interests with shareholders.
Negatives
- No negative information is presented in this filing.
Risks
- No specific risks are mentioned in this Form 4 filing.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This Form 4 filing details an individual insider transaction (RSU vesting and conversion) and does not provide information relevant to broader industry trends or competitive analysis.
Related Party Transactions
- The vesting and conversion of restricted stock units granted to a director (Ellen Beausang) by Aspira Women's Health Inc. constitutes a related party transaction as it involves compensation from the company to an insider.
Stakeholder Impact
- Shareholders: The conversion of RSUs into common stock slightly increases the number of outstanding shares, but this is a standard part of equity compensation plans and is generally expected. It also aligns the director's interests with shareholders.
- Employees: No direct impact on employees is indicated by this filing.
- Customers: No direct impact on customers is indicated by this filing.
- Suppliers: No direct impact on suppliers is indicated by this filing.
- Creditors: No direct impact on creditors is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date Ellen Beausang was granted 6,458 Restricted Stock Units (RSUs). |
| 04/01/2025 | Date a previous Form 4 was filed reporting the RSUs. |
| 06/04/2025 | Date of transaction: 4,843 Restricted Stock Units vested and converted into common stock. |
| 06/05/2025 | Date the Form 4 was signed by Ellen Beausang. |
Keywords
Aspira Women's Health, AWHL, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Common Stock, Director Ownership, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.